Groundbreaking Study Shows Cannabis May Lower Risk of Cognitive Decline and Dementia

https://icaro.icaromediagroup.com/system/images/photos/16173107/original/open-uri20240419-18-gnbyme?1713550475
ICARO Media Group
News
19/04/2024 18h13

A comprehensive study published in the journal Current Alzheimer Research has revealed a significant association between cannabis use and reduced rates of cognitive decline and dementia. The research, conducted on a sample of 4,744 American adults aged 45 and over, examined various methods of cannabis consumption and frequency of use.

The study, which employed self-reporting methods to measure cognitive decline, surprised scientists with its findings. Individuals who used cannabis recreationally had a staggering 96% lower chance of developing what was termed "subjective cognitive decline."

Professor Wong, one of the researchers behind the study, hailed it as a groundbreaking contribution to cannabis research, as it examined multiple dimensions of cannabis use, including smoking, vaping, dabbing, and consuming. Such a comprehensive analysis had not been undertaken before.

"The main takeaway is that cannabis might be protective for our cognition," Professor Wong emphasized. However, the study did not determine whether non-medical cannabis usage led to improved cognition or if individuals with better cognition were more likely to use cannabis recreationally.

An interesting aspect of the study was that it accounted for the distinction between medical-use cannabis, which is higher in CBD (cannabidiol), and recreational-use cannabis, which aims to maximize THC, the psychoactive component. Surprisingly, it was the latter that demonstrated a protective effect on cognition, challenging previous assumptions that CBD was the primary therapeutic element of cannabis.

While recreational cannabis is often used to improve sleep or manage stress, both factors linked to cognitive decline later in life, the study opens up new avenues of research in understanding the potential therapeutic benefits of cannabis.

It is important to note that the study focused on self-reported symptoms and the degree of cognitive decline as determined by the participants. Confounding factors such as depression, anxiety, failing physical health, and personality traits could impact the accuracy of diagnoses for cognitive decline, dementia, and Alzheimer's disease.

Further research is still necessary to fully unravel the complex relationship between cannabis use and cognitive decline. Nonetheless, this study marks a significant milestone in exploring the potential protective effects of cannabis on cognition and sets the stage for future investigations.

The views expressed in this article do not reflect the opinion of ICARO, or any of its affiliates.

Related